Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bond Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Bond Biosciences

Bond Biosciences

Series B

Bond Biosciences: A private biopharma firm developing non-absorbed oral therapeutics for human diseases.

HQ
New York City, NY, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Bond Biosciences, founded with a mission to discover and develop first-in-class non-absorbed oral therapeutics, aims to address ion-related human diseases by binding excess ions locally in the gastrointestinal tract. This privately-held biopharmaceutical company focuses on creating innovative treatments that prevent and treat conditions caused by ion imbalances, leveraging their expertise in non-absorbed therapeutic solutions.

Notable figures affiliated with Bond Biosciences include experienced leaders in biopharmaceutical research and development. The company has achieved significant milestones in its clinical stages, showcasing promising results in treating ion-related disorders. Bond Biosciences' impact lies in its potential to revolutionize treatment paradigms for various GI tract-related diseases, offering new hope for patients through its pioneering therapeutic approach.

Bond Biosciences - Similar Companies

Empire Biotechnologies logo

Empire Biotechnologies

Brii Biosciences logo

Brii Biosciences

briibio.com

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

BridGene Biosciences logo

BridGene Biosciences

BioCryst Pharmaceuticals logo

BioCryst Pharmaceuticals

biocryst.com

BioHealthonomics logo

BioHealthonomics

Precision IBD logo

Precision IBD

Attune Pharmaceuticals logo

Attune Pharmaceuticals

Aibios logo

Aibios

aibios.com

CiVi Biopharma logo

CiVi Biopharma

civibio.com

Palisade Bio logo

Palisade Bio

palisadebio.com

Outpost Medicine logo

Outpost Medicine

Avaxia Biologics logo

Avaxia Biologics

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

BodyBio logo

BodyBio

bodybio.co.uk

Bond Biosciences - Quick Facts

Who are Bond Biosciences' competitors?

Companies similar to Bond Biosciences include Empire Biotechnologies, Brii Biosciences, Reactive Biosciences and BridGene Biosciences.

When was Bond Biosciences founded?

Bond Biosciences was founded in 2016.

Where is Bond Biosciences' headquarters located?

Bond Biosciences' headquarters is located in New York City, NY, US.

When was Bond Biosciences' last funding round?

Bond Biosciences' most recent funding round was for $6.8M (USD) in December 2021.

How much has Bond Biosciences raised to-date?

As of Dec 30, 2021, Bond Biosciences has raised a total of $11.8M (USD).

How many employees does Bond Biosciences have?

Bond Biosciences has 7 employees as of Feb 5, 2024.

Bond Biosciences - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified